Facial & Body Reshaping with Implants — Cost, Top Hospitals & Success Rates | MyMedicPlus

Alloplastic implant surgery uses biocompatible, surgically implanted materials to augment, project, or reshape bony and soft-tissue contours of the face and body. Unlike autologous fat transfer or filler injections, implants provide permanent, predictable volume with dimensional stability and are not subject to resorption over time. The indications span both functional and aesthetic objectives, from correcting severe microgenia (chin underprojection) that impacts occlusion and airway, to enhancing athletic or aesthetic body contours in individuals who lack sufficient donor fat for lipofilling.

Facial implants most commonly target the chin (mentum), cheeks (malar and submalar region), and jaw angle (gonial angle) — areas where skeletal projection significantly influences facial harmony, profile balance, and the perception of facial ageing. Body implants address regions including the calves (for congenital or post-traumatic calf hypoplasia, or aesthetic leg contouring) and the buttocks (gluteal augmentation for volume, projection, and shape).

The choice of implant material — solid silicone, porous polyethylene (Medpor/ePTFE), or titanium mesh — depends on the anatomical site, the degree of augmentation required, whether tissue ingrowth and fixation are desirable, and surgeon preference. Solid silicone implants are the most widely used for facial augmentation due to their ease of insertion, removal, and repositioning. Porous polyethylene allows tissue ingrowth but is more difficult to remove if complications arise. Titanium mesh, primarily used for craniofacial reconstruction, offers structural rigidity and custom three-dimensional fabrication via CT-guided milling.

Reshaping implants are indicated for a broad spectrum of aesthetic and reconstructive deficiencies across the face and body:

• Chin underprojection (microgenia): The most frequently performed facial implant procedure. A deficient chin reduces apparent midface height, compromises the facial profile, and creates an imbalanced relationship with the nose (creating the illusion of a more prominent nose). Chin implants provide 4–12 mm of forward projection depending on style and size.
• Cheek / malar deficiency: Flat or recessive cheekbones reduce midface volume and accelerate the appearance of ageing (descent of soft tissue is more visible over a flat skeleton). Cheek implants are placed over the malar eminence (malar augmentation), below it (submalar — to restore lower cheek fullness), or spanning both regions (combined malar-submalar shell).
• Jaw angle (gonial angle) deficiency: Underdeveloped jaw angles produce a narrow, tapered lower facial shape. Jaw angle implants increase bigonial width and create a more defined mandibular border. Particularly sought for masculine facial contouring and in certain gender-affirming facial masculinisation surgeries.
• Calf hypoplasia: Congenital underdevelopment of the gastrocnemius muscle (more common in the medial head) or post-traumatic/post-neurological muscle atrophy. Calf implants (intramuscular silicone) restore lower limb symmetry and proportion.
• Gluteal deficiency: Absent or insufficient gluteal projection and volume, not correctable by exercise, due to low body fat, prior weight loss, or ageing. Buttock implants (solid silicone, intramuscular or subfascial) provide permanent augmentation.
• Post-reconstruction defects: After mandibular cancer resection, tumour removal, or traumatic facial bone loss, custom alloplastic implants fabricated from CT imaging restore contour and volume.

Candidacy for reshaping implant surgery requires a multidimensional assessment encompassing anatomy, health status, and psychological readiness:

• Skeletal maturity: Facial bones complete growth by approximately age 18 in women and 20–21 in men. Facial implants placed before skeletal maturity risk displacement as the skeleton continues to develop. Body implants (calf, buttocks) are similarly deferred until physical maturity.
• Body weight stability: Patients with fluctuating weight are counselled that significant subsequent weight gain or loss will alter the aesthetic result of the implant. A stable weight for at least 6–12 months is recommended before gluteal or calf augmentation.
• Adequate soft tissue coverage: Implants require sufficient overlying soft tissue to prevent implant visibility, palpability, and edge definition. Very thin patients with minimal subcutaneous fat over the cheekbones or chin may have visible implant edges; fat grafting to improve soft tissue coverage can be combined with implant placement.
• Psychological evaluation: A thorough assessment of motivations, expectations, and body image is essential. Patients with body dysmorphic disorder (BDD) are at higher risk of dissatisfaction regardless of the technical outcome and should be evaluated by a mental health professional before surgery is undertaken.
• No active infection or dental disease: For facial implants placed via intraoral incisions, active periodontal disease or tooth root infections significantly increase the risk of implant contamination and infection. Dental clearance is required before surgery.
• Medical fitness: Standard pre-operative cardiovascular, haematological, and metabolic screening. Patients taking anticoagulants, steroids, or immunosuppressants require management planning with the surgical team before implant placement.

Treatment planning involves selecting the appropriate implant type, material, and surgical access route for each anatomical site:

• Chin implants (mentoplasty): Standard shell implants augment the anterior chin point only. Extended anatomical implants additionally augment the parasymphyseal and premandibular regions, improving definition along the mandibular border. Placed via a submental (chin crease) or intraoral incision in a subperiosteal pocket directly overlying bone. Solid silicone is the most common material for facial implants — smooth, stable, removable, and well-tolerated. Medpor (porous polyethylene) allows tissue ingrowth and resists migration but is more difficult to remove if infection or malposition occurs. Custom titanium mesh implants, fabricated from pre-operative CT imaging, are used for complex reconstructive scenarios.
• Cheek (malar) implants: Placed in a submalar, malar, or combined position via an upper buccal sulcus (intraoral) or lower eyelid (subciliary) incision in the subperiosteal plane. Submalar implants restore midface fullness below the cheekbone, addressing the "flat cheek" appearance. Malar implants augment the cheekbone itself, increasing malar projection. Combined malar-submalar shell implants address both areas simultaneously and are the most versatile option.
• Jaw angle implants: Placed via intraoral posterior buccal sulcus incisions in a subperiosteal pocket over the gonial angle of the mandible. Available in wrap-around designs that extend along the mandibular border for a continuous angular definition. Bilateral placement is mandatory for symmetry.
• Calf implants: Solid silicone implants placed in the subfascial or intramuscular plane (deep to or within the gastrocnemius muscle), accessed via a popliteal crease (posterior knee) incision. Intramuscular placement reduces visible implant edges and palpability but requires more precise technique. Unilateral or bilateral depending on whether asymmetry correction or global augmentation is the objective.
• Buttock implants (gluteal augmentation): Placed via a midline intergluteal cleft or bilateral para-midline incision. Intramuscular placement (within the gluteus maximus) offers greater stability and lower infection rates but is technically more demanding and more painful during recovery. Subfascial placement (between the fascia and muscle) is technically easier with lower muscle-related complications but higher implant visibility and edge palpability in lean patients. Solid silicone (not gel-filled) implants only — gel-filled implants are contraindicated for gluteal use. Compared with fat transfer (Brazilian Butt Lift, BBL), implants are preferred when the patient lacks sufficient donor fat or when large, permanent volume is required, though BBL carries a lower complication rate for mild-to-moderate augmentation.

Alloplastic implant reshaping offers distinctive advantages that make it the preferred approach for specific clinical scenarios:

• Permanence and dimensional stability: Unlike injectable fillers (12–18 months) or fat transfer (30–60% resorption), solid implants provide permanent, predictable augmentation that does not diminish over time or require retreatment.
• Precise and customisable projection: Implants are manufactured in a range of sizes, shapes, and projections. Custom milled implants (for complex facial anatomy) can be fabricated precisely to individual CT-based measurements, providing millimetre-accurate contour correction not achievable with soft-tissue methods.
• Facial harmony and proportion: Chin augmentation is one of the most aesthetically efficient procedures available — a correctly sized chin implant improves the nasolabial angle, reduces the apparent nasal projection, strengthens the cervicomental angle, and fundamentally improves facial profile balance in one outpatient procedure.
• Reversibility (for solid silicone): Solid silicone facial implants are readily removed or exchanged if the patient is dissatisfied with size, position, or develops a complication. This reversibility distinguishes them from porous polyethylene implants, which allow tissue ingrowth and are more difficult to remove.
• Combined procedures: Facial implants are frequently combined with rhinoplasty, facelift, or fat grafting in a single anaesthetic, addressing multiple anatomical imbalances simultaneously and reducing overall recovery time and cost compared to staged procedures.

The complication profile of alloplastic implants varies by anatomical site, implant material, and surgical technique. Key risks include:

• Infection: The most feared complication of alloplastic implantation, as biofilm formation on the implant surface can render antibiotic treatment insufficient, ultimately requiring implant explantation. The incidence for facial implants is approximately 1–3%; for buttock implants, 3–8% (higher due to proximity to perianal flora). Management protocol: early infection (within 2 weeks) — intensive IV antibiotics, irrigation; established infection — explantation, 6-month antibiotic course, reimplantation after 3–6 months of clear tissue.
• Implant malposition and migration: An improperly sized pocket or failure to fixate the implant (with titanium screws if required) can allow rotation or displacement over time. Malposition is more common for cheek and jaw angle implants, which have less bony contact surface than chin implants. Revision surgery is required.
• Capsular contracture: The formation of a thick fibrous capsule around the implant that squeezes and distorts it. Capsular contracture is rare with facial solid silicone implants (less than 1%) due to subperiosteal pocket placement, but is a more clinically relevant risk for calf and buttock silicone implants (reported in 3–10% of cases). Classified by Baker scale (I–IV); severe contracture (Baker III–IV) requires capsulectomy and implant exchange.
• Nerve injury: The mental nerve (sensation of the lower lip and chin) and infraorbital nerve (sensation of the cheek and upper lip) are at risk during chin and cheek implant placement respectively. Precise subperiosteal pocket dissection and accurate implant sizing minimise this risk. Transient paraesthesia (numbness) is common and usually resolves within weeks to months; permanent numbness is reported in less than 1% of cases with experienced surgeons.
• Implant palpability and visibility: In patients with thin overlying soft tissue, implant edges may be visible or palpable. This is addressed by selecting implants with tapered edges, ensuring adequate pocket size, and optionally combining with fat grafting to augment soft-tissue coverage.
• Asymmetry: Minor pre-existing facial asymmetry may be accentuated by symmetric implant placement. Three-dimensional planning and custom-milled implants reduce this risk for complex cases.

Recovery requirements and follow-up protocols differ by implant site:

• Facial implants (chin, cheek, jaw angle): Significant swelling and bruising for the first 1–2 weeks is expected. A soft diet for 2 weeks reduces stress on intraoral incisions. Patients are advised against excessive facial movements that risk implant displacement in the first 6 weeks while the capsule matures. Compression dressings are sometimes applied to chin implants to reduce seroma. Most patients return to office work in 7–10 days; social presentability (resolution of most visible bruising) at 2 weeks. Final result is assessed at 3–6 months once oedema fully resolves.
• Calf implants: Walking is permitted from day one but long-distance walking and standing should be restricted for the first 2 weeks. Strenuous lower-body exercise (running, resistance training) is deferred for 6 weeks. Significant calf firmness and tightness during the initial weeks is expected as the muscle accommodates the implant. Final result is assessed at 3 months.
• Buttock implants: The most demanding recovery of any reshaping implant. Sitting directly on the buttocks is avoided for 2–3 weeks; patients use a donut-shaped cushion or lie in the lateral decubitus position. Driving is prohibited for 3–4 weeks. Return to sedentary work at 3–4 weeks; strenuous activity at 6–8 weeks. Wound dehiscence in the intergluteal cleft is a recognised complication due to high skin tension and perianal bacterial contamination in this region.
• Long-term monitoring: Annual review is recommended for body implants to assess for early capsular contracture, malposition, or implant degradation. Facial implants do not require routine imaging in the absence of symptoms.

Implant reshaping costs include the surgeon's fee, anaesthetist, facility, implant material, and post-operative care:

• Chin implants: USD 2,500–6,000 in the US and Western Europe (all-inclusive surgical fee). South Korea, which has the world's highest per-capita rate of facial implant surgery, charges USD 1,500–3,500 for the same procedure at internationally accredited clinics.
• Cheek implants: USD 3,500–7,500 in the US; USD 1,500–3,500 at major medical tourism destinations (South Korea, Thailand, Turkey, India). Combined cheek and chin augmentation is often packaged at a discount.
• Jaw angle implants: USD 3,000–7,000 in Western markets; USD 1,500–3,500 internationally. Custom milled implants add USD 500–2,000 to the implant material cost.
• Calf implants: USD 4,000–9,000 (bilateral) in the US and Western Europe. Medical tourism pricing ranges from USD 2,500–5,000 at accredited plastic surgery centres in Thailand, South Korea, or Turkey.
• Buttock implants: USD 6,000–14,000 in the US (surgeon fee plus facility and anaesthesia). International pricing at qualified centres: USD 3,000–7,000. Fat transfer Brazilian Butt Lift (BBL) is typically 20–40% less expensive than implants for similar augmentation, where sufficient donor fat is available.
• Medical tourism considerations: Total cost including travel and accommodation for a chin and cheek implant procedure in South Korea or Turkey can be 40–60% lower than the same procedure in the US or UK. The Association of Plastic Surgeons of the relevant destination country and ISAPS (International Society of Aesthetic Plastic Surgery) membership are reliable markers of qualified surgeons.

Several non-implant approaches to facial and body reshaping merit serious consideration, particularly for patients who prefer reversible or minimally invasive options:

• Autologous fat transfer (lipofilling): Harvested fat is processed and injected into the target area. Avoids synthetic materials entirely; produces a natural texture and consistency. The primary limitation is 30–60% resorption of the injected volume, requiring overcorrection or repeat procedures. Excellent for facial rejuvenation, subtle cheek enhancement, and body contouring where implants would be excessive. Brazilian Butt Lift (BBL) fat transfer to the buttocks carries a specific risk of fatal fat embolism if fat is inadvertently injected into the gluteal vasculature — mandating strict injection depth protocols (subcutaneous layer only).
• Injectable dermal fillers: Hyaluronic acid fillers (Juvederm Voluma, Restylane Lyft) can augment the chin, cheekbones, and jaw angle with no surgery, downtime, or recovery. Results last 12–24 months and are fully reversible with hyaluronidase. Best suited to moderate volume needs; not a substitute for the permanent, substantial augmentation achievable with implants.
• Orthognathic (jaw) surgery: For patients with significant chin underprojection related to mandibular retrognathia, genioplasty (surgical osteotomy and repositioning of the chin bone) or orthognathic surgery addresses both the functional (occlusal) and aesthetic deficit with a biological (no foreign material) solution. Genioplasty is preferred by some surgeons over implants for very large chin projections or where vertical height adjustment is also needed.
• Thread lifts and non-surgical face contouring: PDO thread lifting, HIFU (high-intensity focused ultrasound), and radiofrequency microneedling improve soft-tissue positioning and skin laxity. These do not address skeletal deficiency and are not alternatives for structural reshaping; they are complementary for patients whose concerns are primarily about tissue descent rather than skeletal projection.